Featured Research

from universities, journals, and other organizations

Facing Fears Early May Reduce Childhood Anxiety

Date:
October 30, 2008
Source:
Mayo Clinic
Summary:
Helping children face their fears may be more productive than focusing on other techniques to help them manage their anxieties, according to new research.

Helping children face their fears may be more productive than focusing on other techniques to help them manage their anxieties, according to research presented at the annual meeting of the American Academy of Child and Adolescent Psychiatry in Chicago.

The research, which identified similarities between cognitive behavioral therapy administered in a clinical practice and protocols recommended in common treatment manuals, showed that as children were taught to face their fears, their ability to function increased.

The study also showed that children were able to complete exercises exposing them to their fears much earlier than suggested in the treatment manuals. The more children focused on other techniques for managing their anxieties, however, the less improvement they showed in functioning.

Stephen Whiteside, Ph.D., from Mayo Clinic in Rochester, Minn., explained that more research into treatment options for childhood anxiety needs to be conducted. "We have children face their fears and we teach them techniques for managing their anxiety, but research isn't advanced enough to show which element should be the main part of treatment or whether both parts are necessary for improvement," he says.

Dr. Whiteside also says that treatment manuals suggest introducing exposure -- having children face their fears -- late in the treatment process. "We wondered whether we could begin exposures closer to the beginning of the process," Dr. Whiteside says. "If we focused on exposures and didn't provide anxiety management techniques, would kids still get better?"

According to Dr. Whiteside, treatment that was shorter and began exposures earlier than standard manuals recommended not only improved the children's ability to function but also could to be more cost-effective.

Jennifer Vande Voort, M.D., and Stephen Whiteside, Ph.D., both of Mayo Clinic in Rochester, Minn., will present this research entitled, "Exposure Therapy for Childhood Anxiety in Clinical Practice Versus an Empirically Supported Manual" during the AACAP annual meeting at the Sheraton Chicago Hotel and Towers on Oct. 29.


Story Source:

The above story is based on materials provided by Mayo Clinic. Note: Materials may be edited for content and length.


Cite This Page:

Mayo Clinic. "Facing Fears Early May Reduce Childhood Anxiety." ScienceDaily. ScienceDaily, 30 October 2008. <www.sciencedaily.com/releases/2008/10/081029181548.htm>.
Mayo Clinic. (2008, October 30). Facing Fears Early May Reduce Childhood Anxiety. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2008/10/081029181548.htm
Mayo Clinic. "Facing Fears Early May Reduce Childhood Anxiety." ScienceDaily. www.sciencedaily.com/releases/2008/10/081029181548.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins